Stockreport

Denali Therapeutics (DNLI) Is Down 13.9% After First BBB-Crossing Hunter Therapy Wins FDA Nod - What's Changed [Yahoo! Finance]

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com
PDF therapy for neurologic manifestations of Hunter syndrome in eligible pediatric patients, based on cerebrospinal fluid biomarker reduction and supported by Phase 1/2 data [Read more]